Health Advisory: Increased Risk of Severe West Nile Virus and Other Arboviral Diseases in Patients Receiving B Cell-Depleting or B Cell-Modulating Medications
HEALTH ALERT NETWORK Health District 4 Advisory for Healthcare Providers August 21, 2026 Key Actions for Healthcare Providers Educate patients receiving B cell-depleting or B cell-modulating therapies (particularly anti-CD20 monoclonal antibodies) about their increased risk for severe arboviral disease and the importance of mosquito and tick bite prevention. Maintain a high index of suspicion for…